More about

Hepatocellular Carcinoma

News
April 10, 2025
2 min read
Save

Statin use linked to lower risk for HCC, decompensation in chronic liver disease

Statins appeared to reduce the risk for hepatocellular carcinoma and hepatic decompensation among patients with chronic liver disease, according to findings in JAMA Internal Medicine.

News
April 09, 2025
3 min read
Save

Adults diagnosed with type 2 diabetes may have increased risk for obesity-related cancers

Adults who develop new-onset type 2 diabetes may have increased risk for obesity-related cancers compared with those without type 2 diabetes, though associations vary between men and women, according to new data.

News
February 04, 2025
2 min read
Save

US cases of MASLD projected to top 121 million by 2050 alongside 55% spike in MASH

A new model has projected a substantial rise in the burden of metabolic dysfunction-associated steatotic liver disease in the U.S. by 2050, which could be minimized by effective preventive and management strategies, researchers wrote.

News
December 27, 2024
1 min read
Save

FDA approves Opdivo as subcutaneous injection

The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release.

News
December 12, 2024
2 min read
Save

Older age, not comorbidity, linked to worse survival in hepatocellular carcinoma

Older age but not high comorbidity burden was significantly associated with overall survival among patients with hepatocellular carcinoma, even those with early-stage disease, according to study results.

News
December 06, 2024
2 min read
Save

HCC incidence nearly 5-times higher among HBV, HDV coinfected patients with cirrhosis

Incidence of hepatocellular carcinoma was significantly higher among cirrhotic patients coinfected with hepatitis B and D viruses compared with those with HBV alone, with researchers suggesting HDV “plays a direct role” in HCC occurrence.

News
November 19, 2024
2 min read
Save

Naltrexone reduced mortality risk by 17% in decompensated alcohol-associated cirrhosis

SAN DIEGO — Patients with decompensated alcohol-associated cirrhosis and ascites taking naltrexone had lower risk for all-cause mortality and liver disease complications, including acute kidney injury and spontaneous bacterial peritonitis.

News
November 18, 2024
2 min read
Save

Liver stiffness measurements may ‘personalize’ HCC risk, surveillance needs in MASLD

SAN DIEGO — Liver stiffness measurements may help predict the risk for hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease, as well as identify those in need of surveillance, according to data.

News
October 24, 2024
3 min read
Save

Hepatocellular carcinoma survival data highlight importance of early detection

Survival for people with hepatocellular carcinoma has improved over the last decade, according to study results.

News
October 21, 2024
2 min read
Save

Anti-HDV positive individuals at ‘significantly higher risk’ for cirrhosis, HCC

Patients who tested positive for hepatitis D virus antibodies were at greater risk for developing hepatocellular carcinoma and other adverse liver-related outcomes, often at a young age, according to study results.

View more